| Application no. and date | 20740038.3 (espacenet) (Federated) (European Patent Register), 20200717 | | Patent/reg. no. and date | DK/EP 3999080, 20230726 | | Publication date | 20220525 | | Priority no. and date | EP 19305963, 20190719 | | EP pub. no. and date |
EP 3999080 20220525 | | Effective date | | | Applicant/owner | Institut National de la Santé et de la Recherche Médicale
, 101, rue de Tolbiac
75013 Paris, FR,
Institut Gustave-Roussy, 39, rue Camille Desmoulins
94800 Villejuif, FR,
Université Paris-Saclay, Bâtiment Breguet
3 Rue Joliot Curie
91190 Gif sur Yvette, FR | | Applicant ref. no. | | | Inventor | Perfettini, Jean-Luc, 15 avenue Gallieni
77100 Meaux, FR,
ALLOUCH, Awatef, 9 rue du 2 Décembre 1870
94360 Bry sur Marne, FR,
DEUTSCH, Eric, 76 Boulevard Beaumarchais
75011 PARIS, FR | | Representative | | | Opponent | | | IPC Class | A61K 35/15 (2015.01) , A61K 39/00 (2006.01) , C12N 5/0786 (2010.01) | | Title | P21 EXPRESSING MONOCYTES FOR CANCER CELL THERAPY | | Int. application no. | EP2020070379 | | Int. publication no. | WO2021013764 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
